Oncology Consultants- Texas Medical Center

Houston, Texas 77030

1 studies enrolling now · 3 studies all time

What they study most

Advanced Lung Carcinoma, KRAS G12C, Locally Advanced or Metastatic Solid Tumor, Metastatic Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Metastatic Non-Squamous Non-Small Cell Lung Cancer, NSCLC, Non-small Cell Lung Cancer

Studies at this site

• Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer — Recruiting now
• Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer — Completed
• A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors — Stopped early